Finding 504719 (2022-002)

Material Weakness
Requirement
ABEJ
Questioned Costs
$1
Year
2022
Accepted
2024-11-05
Audit: 327330
Organization: Inova Health System (VA)

AI Summary

  • Core Issue: Internal controls were inadequate, leading to failure in verifying client eligibility documentation before providing services.
  • Impacted Requirements: Compliance with federal regulations and pass-through entity agreements regarding client eligibility documentation was not met, risking unallowable costs.
  • Recommended Follow-Up: Strengthen oversight and adherence to policies for eligibility verification to ensure compliance and prevent future issues.

Finding Text

Federal Program Information Federal Agencies: Department of Health and Human Services Pass-Through Entity: Virginia Department of Health Pass-Through Entity Number: INORWB611-GY21; INORWB611-GY22; INORPS611-FY22; INORPS611-FY23 Awards: Assistance Listing Number 93.917 HIV Care Formula Grants (Part B) Award Periods: April 1, 2021 to March 31, 2022: April 1, 2022 to March 31, 2023; July 1, 2021 to June 30, 2022; July 1, 2022 to March 31, 2023 Description: Review and Retention of Eligibility Required Documentation Type of Finding: Material Weakness in Internal Control Over Compliance Criteria In accordance with Title 2 U.S. Code of Federal Regulations, Part 200.303, Internal controls, “Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award.” Per the terms and conditions of the pass-through entity agreement between the Virginia Department of Health (the Department) and the Inova Juniper Program (IJP), IJP “is required to collect the following documentation for client eligibility: (a) Legible documentation for proof of residency in Virginia, (b) Legible documents for proof of a medical diagnosis of a HIV disease (required only once for each client), (c) Legible documentation or proof of household income no greater than 500% of the Poverty Level Guidelines, and (d) Legible documentation for proof that the client does not have insurance (including Medicaid) or other program coverage for the services that the client is seeking from the RW Part B Program. Medicaid-enrolled clients who have access to HIV medications are not eligible for VA MAP services.” (INORWB611-GY22 – Client Eligibility Section E.1, INORPS611-FY23 Section A.1). IJP “will maintain an eligibility checklist and required eligibility documentation in one place in each client file” (INORWB611-GY22 – Client Eligibility Section E.3, INORPS611-FY23 Section A.2). Further, IJP “will verify client eligibility status prior to providing services, including HIV medication services” (INORWB611-GY22 – Client Eligibility Section E.4, INORPS611-FY23 Section A.3). IJP “will not receive reimbursement by the Department for any services provided to clients whose eligibility was not current at the time of service” (INORWB611-GY22 – Client Eligibility Section E.6, INORPS611-FY23 Section A.5). The requirements within the pass-through entity agreement with the Department are consistent with those required by the original Federal awarding agency, the Department of Health and Human Services (DHHS), U.S. Health Resources and Services Administration (HRSA). Per the National Monitoring Standards for Part B included on the official HRSA website, it is the provider/subgrantee’s responsibility to “maintain client records that contain documentation of the client’s eligibility determination, including the following: Initial Eligibility Determination and Recertification Documentation Requirements: (1) HIV diagnosis (2) Proof of residency (3) Low Income (4) Uninsured or underinsured status.” HRSA aligns with the Public Service Health Act Section 2616 – Provision of Treatment (b) (1-2) which states “to be eligible to receive assistance from a State under this section an individual shall (1) have a medical diagnosis of HIV/AIDS; and (2) be a low-income individual, as defined by the State.” Per the National Monitoring Standards for Part B included on the official HRSA website, “Income made from charges to RWHAP Part B clients or to insurance companies for services performed is considered program income.” Condition The System did not have appropriately designed internal controls in place to ensure that the documentation is obtained and reviewed to verify eligibility prior to providing services. Cause IJP has policies and procedures in place to obtain the eligibility documents from all clients and retain in their files. IJP’s policies and procedures specify that an eligibility worker will meet with each client for an initial screening to verify residency, income, insurance status, and HIV status. The eligibility worker is required to meet with the client to update the required eligibility screening and include the required documentation in the client file. Additionally, at each subsequent visit, the receptionist questions each client as to whether there have been any changes in their income or insurance status. If there are changes to the client’s eligibility status, another visit is scheduled with the eligibility worker. Management identified that these policies and procedures were not followed during the year due to lack of oversight and related under performance from various eligibility workers employed during the year.  Effect or potential effect Eligibility workers did not obtain and/or retain the required documentation related to the eligibility screening for certain clients. Services continued to be provided and related costs were reimbursed by DHHS. Based on the terms and conditions of the pass-through agreement with DHHS, the clients whose eligibility was not current at the time of service would not be considered eligible and any reimbursed cost would represent unallowable costs. Furthermore, program income represents income made from charges to RW Part B eligible clients or to insurance companies for services performed. Program income was recognized on services and charges for clients whose eligibility was not current at the time of service. For clients that received services in 2022, IJP recognized $332,344 of program income during the year. Questioned costs Indeterminable. Identification of a repeat finding This is not a repeat finding. Context During our audit, we selected a sample of 60 clients for testing and noted the following 3 exceptions: • There was no evidence of documentation obtained to prove that the client did not have insurance (including Medicaid) or other program coverage for the services provided for one client. • There was no evidence of documentation obtained to prove that the client did not have household income no greater than 500% of the Poverty Level Guidelines for one client. • The documentation for support proof that the client did not have household income no greater than 500% of the Poverty Level Guidelines was retained; however, for one client, the support indicated that they exceeded the Poverty Level Guidelines and services were provided. IJP has not completed a full review of all clients that could be impacted by the exceptions above. Further, IJP does not track reimbursed costs at the individual client level. As such, the costs associated with this finding are indeterminable. Recommendation IJP’s existing policies and procedures are in line with the requirements of the pass-through agreement with DHHS; however, IJP should continue to evaluate whether appropriate oversight is performed to ensure that these policies and procedures are being followed with regard to eligibility verification including maintaining the requirement documentation for all clients. View of responsible officials Management concurs with the finding and will implement procedures to ensure that the appropriate oversight is performed with regard to eligibility.

Corrective Action Plan

Federal Award Finding and Questioned Costs Finding Reference Number: 2022-002 – Activities Allowed or Unallowed, Allowable Costs/ Cost Principles, Eligibility and Program Income Federal Program Information: Federal Agency: U.S. Department of Health and Human Services Pass-Through Entity: Virginia Department of Health Pass-Through Entity Number: INORWB611-GY21; INORWB611-GY22 INORPS611-FY22; INORPS611-FY23 Awards: Assistance Listing Number 93.917 HIV Care Formula Grants (Part B) Award Periods: April 1, 2021 to March 31, 2022; April 1, 2022 to March 31, 2023 July 1, 2021 to June 30, 2022; July 1, 2022 to March 31, 2023 Description: Review and Retention of Eligibility Required Documentation Type of Funding: Material Weakness in Internal Control Over Compliance Recommendation: Inova Juniper Program’s (IJP) existing policies and procedures are in line with the requirements of the pass-through agreement with the Department; however, IJP should continue to evaluate whether appropriate oversight is performed to ensure that these policies and procedures are being followed with regard to eligibility verification for all clients. View of Responsible Officials: Management concurs with the finding and has implemented, during 2021 and 2022, procedures to ensure the appropriate oversight is performed regarding eligibility. Name(s) of the Contact Person(s) Responsible for Corrective Action: Christopher T. Smith, Vice President of Finance and Corporate Controller, 571-472-8122. Christopher Trump, Senior Director of Financial Reporting, 571-373-2868. Michael H. Lowen, Director, Grant Accounting, 571-472-8108. Mara Carter, Senior Director Community Health, Inova Juniper Program, 703-321-2687 Corrective Action Planned: All exceptions noted during testing were from eligibility certifications prior to the actions noted below. Patients were not due to have re-certifications done at the time the services were provided. Below are the policies and procedures implemented and the control activities to ensure that policies and procedures are being followed with regard to eligibility verification for all clients.  VDH Part B Eligibility standards were modified to help reduce the documentation burden in which the annual eligibility screening was extended to a 24-month eligibility review and removal of the six-month recertification requirement. This was incorporated within the VDH contract on April 1, 2022.  Effective November 1, 2021, the list of acceptable documents changed by VDH. Bank statements were no longer an acceptable proof of residency and viral load values had to be included versus only lab results with undetectable. Also, VDH implemented a new eligibility electronic health record (EHR), Provide Enterprise, to help ensure all eligibility requirements are met for each Ryan White patient. Although this was implemented statewide, Inova continued to utilize the Provide Portal and went live with Provide Enterprise in January 2023. The existing Provide Portal at Juniper did not have an income calculator or the ability to immediately provide feedback that the required forms and eligibility requirement was not met. The new system in place, Provide Enterprise, has both functionalities.  Inova has strict monitoring practices in place. The practice manager in 2021 and new Senior Practice Manager who started in July 2022 reviewed 110-120 charts monthly, and our Business Analyst performed a 10% reaudit of those charts. The audits completed in 2022 were a result of the implemented processes due to the corrective action plan of the previous audit. These ongoing audits assist management to closely monitor adherence to the changes adopted in 2021 and 2022. If any gaps are noted during the audit, the Senior Practice Manager works with the team to fix discrepancies within seven working days. The goal of the monitoring process is to ensure adopted policies and procedures with respect to eligibility are followed.  In November 2022, a peer review process was implemented by the Senior Practice Manager to ensure prior submission to any eligibility packet to VDH, there is a second independent review of each packet. This ensures all internal processes are followed. After November 2022, weekly meetings continued with all eligibility team members and leadership. The peer review focuses mainly on proof of documentation for each requirement and income calculations.  Inova Juniper Program implemented a revised policy in February 2023. Once Provide Enterprise was fully implemented in February 2023, VDH also added a quality assurance meeting weekly to review all previously submitted packets for the week. The goal is to identify any gaps and opportunities in our processes. The revised policy focuses on the new EHR, Provide Enterprise, capability and to ensure processes include use of the income calculator and compliance with appropriate use of documents related to eligibility.  All team members went through a robust Provide Enterprise training and all new hires are required to attend the same training. This training incorporates all the appropriate documents needed to be eligible for Ryan White services as well as utilizing the income calculator. The Leadership team, and our internal quality council, review our eligibility scorecards monthly and discuss any trends or opportunities. In addition to the above, leadership also reviewed all job descriptions for our current eligibility team. It was determined based on the scope of their role, that realignment was necessary. The Patient Access Associate (PAA) I role did not require any healthcare or registration experience in order to accurately perform their role. The job focused purely on customer service experience and was an entry level position for the program. The PAA II role requires one year of healthcare registration or revenue cycle experience and the PAA III roles require two years’ experience in healthcare registration or revenue cycle. Given the level of detail orientation required for these positions and the ability to fully understand registration, HIPAA, insurance verification and grant mandates, all individuals with the appropriate requirements that were identified as PAA I roles were transitioned to PAA II and PAA III. Through attrition, all roles have successfully been reassigned. Planned Completion Date for Corrective Action Planned: Corrective action plan has been implemented.

Categories

Questioned Costs Subrecipient Monitoring Allowable Costs / Cost Principles Internal Control / Segregation of Duties

Other Findings in this Audit

  • 504718 2022-001
    Significant Deficiency Repeat
  • 504720 2022-003
    Significant Deficiency Repeat
  • 504721 2022-004
    Material Weakness
  • 1081160 2022-001
    Significant Deficiency Repeat
  • 1081161 2022-002
    Material Weakness
  • 1081162 2022-003
    Significant Deficiency Repeat
  • 1081163 2022-004
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $31.63M
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $12.42M
93.917 Hiv Care Formula Grants $3.05M
12.750 Uniformed Services University Medical Research Projects $2.36M
93.837 Cardiovascular Diseases Research $728,686
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $630,893
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $551,228
93.461 Hrsa Covid-19 Claims Reimbursement for the Uninsured Program and the Covid-19 Coverage Assistance Fund $537,317
93.939 Hiv Prevention Activities Non-Governmental Organization Based $428,237
20.RD Nhtsa Discretionary Safety Grants and Cooperative Agreements $358,219
93.350 National Center for Advancing Translational Sciences $278,879
93.145 Aids Education and Training Centers $249,634
93.RD Population Health Research Support $203,128
93.914 Hiv Emergency Relief Project Grants $168,245
93.767 Children's Health Insurance Program $166,981
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $144,695
93.103 Food and Drug Administration Research $134,239
16.575 Crime Victim Assistance $126,935
93.393 Cancer Cause and Prevention Research $102,253
93.RD Nhlbi Graft Sample and Data Collection Project $80,705
93.394 Cancer Detection and Diagnosis Research $73,677
12.420 Military Medical Research and Development $40,278
93.226 Research on Healthcare Costs, Quality and Outcomes $35,161
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $32,135
93.RD Nhlbi/inova Pulmonary Vascular Program $27,759
93.397 Cancer Centers Support Grants $21,633
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $17,834
21.027 Coronavirus State and Local Fiscal Recovery Funds $13,427
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $13,326
93.RD Nhlbi Pulmonary Vascular Program $7,240
93.855 Allergy and Infectious Diseases Research $5,536
93.RD Support Services for the Lampoon Protocol Ide Enrollment Sites $4,248
93.940 Hiv Prevention Activities Health Department Based $2,126